Journal of Nucleic Acids [26] F. Veglia, G. Matullo, and P. Vineis, “Bulky DNA adducts and risk of cancer: a meta-analysis,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 2, pp. 157–160, 2003. [27] P. J. Borm, A. M. Knaapen, R. P. Schins, R. W. Godschalk, and F. J. Schooten, “Neutrophils amplify the formation of DNA adducts by benzo[a]pyrene in lung target cells,” Environmental Health Perspectives, vol. 105, pp. 1089–1093, 1997. [28] C. Sacerdote, M. Peluso, A. Munnia, C. Malaveille, and P. Vineis, “The choice of controls in a case-control study on WBC-DNA adducts and metabolic polymorphisms,” Biomarkers, vol. 5, no. 4, pp. 307–313, 2000. [29] P. Vineis and F. Perera, “DNA adducts as markers of exposure to carcinogens and risk of cancer,” International Journal of Cancer, vol. 88, no. 3, pp. 325–328, 2000. [30] D. Palli, G. Masala, M. Peluso et al., “The eﬀects of diet on DNA bulky adduct levels are strongly modiﬁed by GSTM1 genotype: a study on 634 subjects,” Carcinogenesis, vol. 25, no. 4, pp. 577–584, 2004. [31] M. Berwick and P. Vineis, “Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review,” Journal of the National Cancer Institute, vol. 92, no. 11, pp. 874–897, 2000. [32] E. Braithwaite, X. Wu, and Z. Wang, “Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell- free extracts: involvement of two excision repair mechanisms in vitro,” Carcinogenesis, vol. 19, no. 7, pp. 1239–1246, 1998. [33] Y. Wang, M. R. Spitz, Y. Zhu, Q. Dong, S. Shete, and X. Wu, “From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity,” DNA Repair, vol. 2, no. 8, pp. 901–908, 2003. [34] Y. Tanaka, Y. Maniwa, V. P. Bermudez et al., “Nonsynonymous single nucleotide polymorphisms in DNA damage repair pathways and lung cancer risk,” Cancer, vol. 116, pp. 896–902, 2010. 7